BaseSpace
Correlation
Engine-Public
Sign In
Register
Correlation Engine 2.0
Home
My Data
Bookmarks
Collaborations
Inbox
Import Your Data
QuickView
FAQ
What is QuickView?
What can my QuickView results tell me?
What are the sources for the General Info tab in QuickView?
More QuickView FAQs
Back to top
QuickView
Curated
Studies
Body
Atlas
Disease
Atlas
Pharmaco
Atlas
Knockdown
Atlas
Genetic
Markers
Pathway
Enrichment
Literature
Clinical
Trials
0
Meta-
Analysis
QuickView
Search sequence regions
(e.g.
rs3825942
,
EGFR
,
Angiogenesis
,
Arthritis
,
Heart
,
Neocentromeres
,
Doxorubicin
)
Organisms
Chromosomes
Start
Stop
Homo Sapiens
Mus Musculus
Rattus Norvegicus
C. Elegans
D. Melanogaster
Saccharomyces Cerevisiae
QuickView
Go back to main search
Bookmark
Forward
QuickView
for
ews fli1
Summary
General Info
Curated Studies
Most Correlated Studies
EWS-FLI1 knockdown in Ewing's sarcoma cell lines
Ewing tumor cell lines depleted of EWS-FLI1 fusion
Ewing sarcoma cell lines with shRNA against EWS-FLI1
EWS-FLI1 transfection in HEK293 cells
Embryonic bone cells expressing EWS-FLI1 fusion; model of Ewing's sarcoma (EWS)
Explore Curated Studies Results
Literature
Most Relevant Literature
Targeted Therapy for EWS-FLI1 in Ewing Sarcoma.
ETV6 dependency in Ewing sarcoma by antagonism of EWS-FLI1-mediated enhancer activation.
Ablation of EWS-FLI1 by USP9X inhibition suppresses cancer cell growth in Ewing sarcoma.
Single-molecule Imaging of EWS-FLI1 Condensates Assembling on DNA.
EWS::FLI1 and HOXD13 Control Tumor Cell Plasticity in Ewing Sarcoma.
Explore Literature Results
Clinical Trials
Most Relevant Clinical Trials
Pbi-shRNAâ„¢ EWS/FLI1 Type 1 LPX in Subjects With Advanced Ewing's Sarcoma
TK216 in Patients With Relapsed or Refractory Ewing Sarcoma
Genetic Biomarkers in Saliva Samples From Patients With Ewing Sarcoma
Palbociclib + Ganitumab In Ewing Sarcoma
A Clinical Study of TK216 in Patients With Relapsed or Refractory Ewing's Sarcoma
Explore Clinical Trials Results
search
→
result
search
→
result
See more about this page
See complete FAQ